Health plan members who receive preventive health examinations, as opposed to going to a physician only when they are sick, appear more likely to undergo testing for colorectal, breast and prostate cancers, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Get the full story...
Hispanics are the fastest growing minority population in the United States, and a Cincinnati medical oncologist says this trend highlights the urgent need for a national health agenda on cancer prevention and education that spans both developed and developing countries.
Get the full story...
Men who have been treated for breast cancer face a significantly high risk of getting cancer once again, according to UC Irvine epidemiologists.
Read the full story
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes. When mutated or deleted, it causes cancers of the prostate, breast, colon, and brain. Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published in the January 12 issue of Cell.
Read the full story
Scientists at the University of Liverpool have found how two molecules fight in the blood to control the spread of cancer cells
Read the full story
A research team at UT Southwestern Medical Center has for the first time identified several genes whose expression is lost in four of the most common solid human cancers - lung, breast, prostate and colon cancer.
Read the full story
